Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
Interview With Charles Gore, Medicines Patent Pool Executive Director

Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going.

Published
23 hours ago
From
Intellectual Property Watch
Should the NIH Break HIV Prevention Drug Truvada's Patent?

Should a biotech giant holding a valuable patent be forced to give it up if doing so would serve the public good? That’s the mounting debate over Gilead Sciences’ hold on an HIV prevention treatment, which some say is too expensive and should be available to all.

Published
05 March 2019
From
Fortune
San Francisco Is Beating H.I.V. Why Can’t Houston?

We know how to fight the epidemic, but patients in the South still aren’t getting the treatment they need.

Published
04 March 2019
From
The New York Times
Examining the Truvada #BreakThePatent Debate: Gilead Responds

A review of how patents affect access to Truvada, and Gilead's response on calls for march-in rights to be granted on patents in order to facilitate access.

Published
04 March 2019
From
IPWatchdog.com
A new way to pay for innovative drugs, provide universal access and not break the bank

Louisiana, which has a severe hepatitis C problem, is on the cusp of proving to other states that drug companies can make the money they need, while every Medicaid recipient who needs a cure gets one. The state is now on a path to secure immediate treatment for all infected prisoners and people on Medicaid by buying a license from a drug company. It is a concept that can be applied to other ground breaking remedies.

Published
28 February 2019
From
The Conversation
'I came to Peru to survive': Venezuelans migrating for HIV drugs

Darwin Zerpa is among those who have fled to Peru to get the antiretrovirals he needs. Now he counsels others with the virus.

Published
24 February 2019
From
The Guardian
US: The struggle to maintain access to lifesaving HIV meds

President Trump actually proposed a plan in his State of the Union address to end the HIV epidemic in America by 2030. This lofty goal would be thwarted, however, by proposed changes to Medicare Part D that jeopardize the advancements we’ve made in the fight against HIV.

Published
24 February 2019
From
Washington Blade
HIV Situation Is “Critical” in Venezuela as Military Withholds Meds

“We are scared for the safety of our activists and call upon the global community to help the people of Venezuela living with HIV.”

Published
20 February 2019
From
Poz
Tackling HIV and hepatitis C in Europe: towards minimum standards

Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in Bucharest featured discussions that could form

Published
08 February 2019
By
Gus Cairns
Glimmers of hope: moving towards better HIV and TB treatment in eastern Europe

Eastern Europe continues to have one of the worst HIV epidemics in the world outside sub-Saharan Africa, with the worst linkage to care of any region in

Published
07 February 2019
By
Gus Cairns
← First12345...68Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.